Pharmabiz46m
Quest Diagnostics awarded US CDC contracts for H5 avian influenza and Oropouche virus test development
Quest Diagnostics awarded US CDC contracts for H5 avian influenza and Oropouche virus test development: Secaucus, New Jersey Thursday, October 24, 2024, 15:00 Hrs [IST] Quest Diag ...
Pharmabiz1h
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...
Pharmabiz1h
JB Pharma outlines key ESG goals and targets in its Third Sustainability Report FY24
JB Pharma outlines key ESG goals and targets in its Third Sustainability Report FY24: Our Bureau, Mumbai Thursday, October 24, 2024, 14:30 Hrs [IST] J B Chemicals & Pharmaceutical ...
Pharmabiz2h
NIHR awards nearly £17 million for global health research projects
The NIHR has awarded nearly £17 million to four new global health research projects. The projects aim to carry out targeted research to prevent, treat and manage multiple long-term conditions (MLTC) ...
Pharmabiz2h
Pfizer receives US FDA approval for its RSV vaccine Abrysvo for adults aged 18 to 59 at increased risk for disease
Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the ...
Pharmabiz22h
Nuclidium announces first patient imaged in phase 1 study evaluating 61Cu-based radiotracer in patients with PSMA-positive
Nuclidium announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging ...
Pharmabiz17h
Find Therapeutics initiates patient dosing in phase 1 study of FTX-101
Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...
Pharmabiz3h
Mankind Pharma completes acquisition of BSV to strengthen its leadership in women’s health
Mankind Pharma completes acquisition of BSV to strengthen its leadership in women’s health: Our Bureau, Benngaluru Thursday, October 24, 2024, 12:15 Hrs [IST] Mankind Pharma has ...
Pharmabiz3h
Virax Biolabs enters distribution agreement with Europa Biosite to commercialize ImmuneSelect in UK & Ireland
Virax Biolabs enters distribution agreement with Europa Biosite to commercialize ImmuneSelect in UK & Ireland: London Thursday, October 24, 2024, 12:00 Hrs [IST] Virax Biolabs Gro ...
Pharmabiz6h
UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease
UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...
Pharmabiz5h
UK’s first norovirus mRNA vaccine trial launched
The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...
Pharmabiz7h
FIHAV 40th Edition to offer key opportunities for Indian pharma companies
FIHAV 40th Edition to offer key opportunities for Indian pharma companies: Our Bureau, Mumbai Thursday, October 24, 2024, 08:00 Hrs [IST] The 40th Edition of the International Tra ...